Home › Funds › Siren, L.L.C. › EWTX
Siren, L.L.C. position in EWTX
EDGEWISE THERAPEUTICS INC · Health Care
Siren, L.L.C. reported holding 2,804,179 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$113.8M, representing 2.70% of its reported portfolio and ranking #9 among its reported holdings. Siren, L.L.C. has disclosed EWTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Siren, L.L.C.'s EWTX position evolved
Siren, L.L.C. first disclosed a stake in EWTX in Q3 2024 at 404,113 shares (US$10.8M). The position peaked in Q1 2026 at 4,430,263 shares, worth US$139.6M. Across 9 filings, Siren, L.L.C. increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,804,179 shares valued at US$113.8M — a reduction of -380,450 shares quarter over quarter.. Notable position changes include a 82% increase in Q4 2024 (shares fell 18% over the following quarter), a 131% increase in Q1 2025 (shares fell 40% over the following quarter), a 86% increase in Q2 2025 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 404.11K | $10.79M | New |
| Q4 2024 | 734.34K | $19.61M | Add |
| Q1 2025 | 1.70M | $37.32M | Add |
| Q2 2025 | 3.16M | $41.43M | Add |
| Q3 2025 | 3.90M | $63.21M | Add |
| Q4 2025 | 4.53M | $112.41M | Add |
| Q1 2026 | 4.43M | $139.55M | Reduce |
| Q2 2026 | 3.18M | $129.39M | Reduce |
| Q3 2026 | 2.80M | $113.85M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EWTX and 13F data
EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EWTX
- ORBIMED ADVISORS LLC 15.52M sh · $630.52M · Q2 2026
- Paradigm Biocapital Advisors LP 10.22M sh · $415.05M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 8.39M sh · $341.00M · Q2 2026
- Novo Holdings A/S 5.35M sh · $217.37M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.73M sh · $192.12M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.37M sh · $177.71M · Q2 2026
- BAKER BROS. ADVISORS LP 3.70M sh · $150.40M · Q2 2026
- Cormorant Asset Management, LP 2.51M sh · $101.98M · Q2 2026
- Integral Health Asset Management, LLC 2.00M sh · $81.26M · Q2 2026
- BRAIDWELL LP 2.00M sh · $81.14M · Q2 2026
- MPM BioImpact LLC 1.62M sh · $65.85M · Q2 2026
- First Light Asset Management, LLC 1.10M sh · $44.50M · Q2 2026
More on Siren, L.L.C.
FAQ
How long has Siren, L.L.C. held EWTX?
Siren, L.L.C. has disclosed EWTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Siren, L.L.C.'s current position in EWTX?
As of Q3 2026, Siren, L.L.C. holds 2.80M shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $113.85M, representing 2.70% of its reported portfolio and ranking #9.
Has Siren, L.L.C. been buying or selling EWTX?
In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in EWTX. The position peaked in Q1 2026 at 4.43M shares.
Which other funds hold EWTX?
Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.